Nisa Investment Advisors LLC Reduces Stock Position in HCA Healthcare, Inc. $HCA

Nisa Investment Advisors LLC decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 10.8% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 58,454 shares of the company’s stock after selling 7,108 shares during the period. Nisa Investment Advisors LLC’s holdings in HCA Healthcare were worth $24,913,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. Abound Wealth Management increased its holdings in HCA Healthcare by 28.0% during the 3rd quarter. Abound Wealth Management now owns 119 shares of the company’s stock worth $51,000 after acquiring an additional 26 shares during the period. ORG Partners LLC raised its position in shares of HCA Healthcare by 27.9% in the second quarter. ORG Partners LLC now owns 142 shares of the company’s stock worth $55,000 after buying an additional 31 shares in the last quarter. Glenview Trust co grew its position in HCA Healthcare by 2.3% during the first quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after buying an additional 32 shares in the last quarter. Optas LLC boosted its position in shares of HCA Healthcare by 4.5% during the 3rd quarter. Optas LLC now owns 760 shares of the company’s stock valued at $324,000 after acquiring an additional 33 shares during the last quarter. Finally, Sivia Capital Partners LLC raised its stake in HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on HCA. Wall Street Zen upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 25th. Wells Fargo & Company upped their price objective on HCA Healthcare from $431.00 to $452.00 and gave the stock an “equal weight” rating in a report on Wednesday. Mizuho increased their price target on shares of HCA Healthcare from $505.00 to $520.00 and gave the company an “outperform” rating in a research report on Thursday, December 18th. Jefferies Financial Group upped their price objective on shares of HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a research note on Tuesday, October 28th. Finally, KeyCorp boosted their price target on shares of HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a research note on Monday, October 27th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $485.95.

Get Our Latest Stock Analysis on HCA Healthcare

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.30% of the stock is owned by insiders.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $472.40 on Friday. HCA Healthcare, Inc. has a 1 year low of $295.00 and a 1 year high of $520.00. The stock’s 50-day moving average is $479.87 and its 200 day moving average is $427.05. The company has a market cap of $107.80 billion, a PE ratio of 18.26, a P/E/G ratio of 1.32 and a beta of 1.36.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business’s revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were paid a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Recommended Stories

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.